Sign inGet started

McGuigan Christopher

Insider CIK 1412484 · TROV Director · INHX Director · SGYP Director · CTRV Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SGYP SYNERGY PHARMACEUTICALS, I A Award deriv2015-07-242015-07-2827,000— $0297,811SEC↗
SGYP SYNERGY PHARMACEUTICALS, I A Award deriv2014-12-062014-12-0962,500— $0270,811SEC↗
CTRV ContraVir Pharmaceuticals, A Award deriv2014-12-032014-12-04118,638— $0415,234SEC↗
SGYP SYNERGY PHARMACEUTICALS, I A Award deriv2014-06-102014-06-1222,000— $0208,311SEC↗
CTRV ContraVir Pharmaceuticals, A Award deriv2014-03-122014-03-1416,596— $0296,596SEC↗
NONE ContraVir Pharmaceuticals, A Award deriv2014-01-242014-01-28250,000— $0280,000SEC↗
SGYP SYNERGY PHARMACEUTICALS, I A Award deriv2013-07-122013-07-1631,906— $0186,311SEC↗
TROV TrovaGene Inc. A Award deriv2013-02-142013-02-217,832— $016,165SEC↗
SGYP SYNERGY PHARMACEUTICALS, I A Award deriv2012-08-072012-08-0920,632— $0154,405SEC↗
SGYP SYNERGY PHARMACEUTICALS, I A Award deriv2012-03-202012-03-2811,250— $0133,773SEC↗
INHX INHIBITEX, INC. D To issuer deriv2012-02-132012-02-1520,000— $00SEC↗
INHX INHIBITEX, INC. D To issuer deriv2012-02-132012-02-1520,000— $00SEC↗
INHX INHIBITEX, INC. D To issuer deriv2012-02-132012-02-1520,000— $00SEC↗
INHX INHIBITEX, INC. D To issuer deriv2012-02-132012-02-1520,000— $00SEC↗
INHX INHIBITEX, INC. D To issuer deriv2012-02-132012-02-157,500— $00SEC↗
INHX INHIBITEX, INC. D To issuer deriv2012-02-132012-02-157,500— $00SEC↗
INHX INHIBITEX, INC. D To issuer deriv2012-02-132012-02-156,600— $00SEC↗
INHX INHIBITEX, INC. D To issuer deriv2012-02-132012-02-1533,000— $00SEC↗
INHX INHIBITEX, INC. A Award deriv2012-02-012012-02-0320,000— $020,000SEC↗